You are here

  • Home
  • Archive
  • Volume 5, Issue 8
  • Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study

Article info

Article menu
XML
Infectious diseases
Research
Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study

Authors

  • Xia Zou Faculty of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, People's Republic of China Sun Yat-sen Centre for Migrant Health Policy, Sun Yat-sen University, Guangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Li Ling Faculty of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, People's Republic of China Sun Yat-sen Centre for Migrant Health Policy, Sun Yat-sen University, Guangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Lei Zhang Sun Yat-sen Centre for Migrant Health Policy, Sun Yat-sen University, Guangzhou, People's Republic of China The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Li Ling; lingli{at}mail.sysu.edu.cn and Lei Zhang; lzhang{at}kirby.unsw.edu.au
View Full Text

Citation

Zou X, Ling L, Zhang L
Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study
BMJ Open 2015;5:e008162. doi: 10.1136/bmjopen-2015-008162

Publication history

  • Received March 11, 2015
  • Revised June 16, 2015
  • Accepted July 14, 2015
  • First published August 21, 2015.
Online issue publication 
October 26, 2017
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/